SLC16A1 and breast carcinoma: However, the study by Jiang et al. [105] demonstrates both in vitro and in vivo that the overexpression of SLC16A1-AS1 suppresses cell viability, proliferation, migration, invasion, and tumor growth in breast cancer through the miR-552-5p/WIF1 signaling pathway.